China Cancer Immunotherapy Market Research Report Forecast 2017-2021

September 2017 | 103 pages | ID: CBA2DAF7ADEEN
S&P Consulting

Abstracts

The China Cancer Immunotherapy Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cancer Immunotherapy industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cancer Immunotherapy market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:
Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis

China Cancer Immunotherapy Market: Product Segment Analysis
Type 1
Type 2
Type 3

China Cancer Immunotherapy Market: Application Segment Analysis
Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 CANCER IMMUNOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Cancer Immunotherapy
1.2 Cancer Immunotherapy Market Segmentation by Type
  1.2.1 China Production Market Share of Cancer Immunotherapy by Type 1n 2016
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Cancer Immunotherapy Market Segmentation by Application
  1.3.1 Cancer Immunotherapy Consumption Market Share by Application in 2016
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size Sales (Value) and Revenue (Volume) of Cancer Immunotherapy (2012-2021)

CHAPTER 2 CHINA ECONOMIC IMPACT ON CANCER IMMUNOTHERAPY INDUSTRY

2.1 China Macroeconomic Environment Analysis
  2.1.1 China Macroeconomic Analysis
  2.1.2 China Macroeconomic Environment Development Trend
2.2 Effects to Cancer Immunotherapy Industry

CHAPTER 3 CHINA CANCER IMMUNOTHERAPY MARKET COMPETITION BY MANUFACTURERS

3.1 China Cancer Immunotherapy Production and Share by Manufacturers (2015 and 2016)
3.2 China Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)
3.3 China Cancer Immunotherapy Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Cancer Immunotherapy Manufacturing Base Distribution, Production Area and Product Type
3.5 Cancer Immunotherapy Market Competitive Situation and Trends
  3.5.1 Cancer Immunotherapy Market Concentration Rate
  3.5.2 Cancer Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 CHINA CANCER IMMUNOTHERAPY CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2012-2017)

4.1 China Cancer Immunotherapy Capacity, Production and Growth (2012-2017)
4.2 China Cancer Immunotherapy Revenue and Growth (2012-2017)
4.3 China Cancer Immunotherapy Production, Consumption, Export and Import (2012-2017)

CHAPTER 5 CHINA CANCER IMMUNOTHERAPY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Cancer Immunotherapy Production and Market Share by Type (2012-2017)
5.2 China Cancer Immunotherapy Revenue and Market Share by Type (2012-2017)
5.3 China Cancer Immunotherapy Price by Type (2012-2017)
5.4 China Cancer Immunotherapy Production Growth by Type (2012-2017)

CHAPTER 6 CHINA CANCER IMMUNOTHERAPY MARKET ANALYSIS BY APPLICATION

6.1 China Cancer Immunotherapy Consumption and Market Share by Application (2012-2017)
6.2 China Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

CHAPTER 7 CHINA CANCER IMMUNOTHERAPY MANUFACTURERS ANALYSIS

7.1 Amgen
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Product Type, Application and Specification
  7.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Business Overview
7.2 AstraZeneca
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Product Type, Application and Specification
  7.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Business Overview
7.3 F. Hoffman La-Roche
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Product Type, Application and Specification
  7.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Business Overview
7.4 Bayer AG
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Product Type, Application and Specification
  7.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Business Overview
7.5 Bristol-Myers Squibb
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Product Type, Application and Specification
  7.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Business Overview
7.6 Eli Lilly and Company
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Product Type, Application and Specification
  7.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Business Overview
7.7 Janssen Global Services
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Product Type, Application and Specification
  7.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Business Overview
7.8 Merck
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Product Type, Application and Specification
  7.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Business Overview
7.9 Novartis
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Product Type, Application and Specification
  7.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Business Overview

CHAPTER 8 CANCER IMMUNOTHERAPY MANUFACTURING COST ANALYSIS

8.1 Cancer Immunotherapy Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Cancer Immunotherapy

CHAPTER 9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Cancer Immunotherapy Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
9.4 Downstream Buyers

CHAPTER 10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

CHAPTER 12 CHINA CANCER IMMUNOTHERAPY MARKET FORECAST (2017-2021)

12.1 China Cancer Immunotherapy Production, Revenue Forecast (2017-2021)
12.2 China Cancer Immunotherapy Production, Consumption Forecast by Regions (2017-2021)
12.3 China Cancer Immunotherapy Production Forecast by Type (2017-2021)
12.4 China Cancer Immunotherapy Consumption Forecast by Application (2017-2021)
12.5 Cancer Immunotherapy Price Forecast (2017-2021)

CHAPTER 13 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Cancer Immunotherapy
Figure China Production Market Share of Cancer Immunotherapy by Type 1n 2016
Table Cancer Immunotherapy Consumption Market Share by Application in 2016
Figure China Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2012-2021)
Table China Cancer Immunotherapy Capacity of Key Manufacturers (2015 and 2016)
Table China Cancer Immunotherapy Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Cancer Immunotherapy Capacity of Key Manufacturers in 2015
Figure China Cancer Immunotherapy Capacity of Key Manufacturers in 2016
Table China Cancer Immunotherapy Production of Key Manufacturers (2015 and 2016)
Table China Cancer Immunotherapy Production Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Immunotherapy Production Share by Manufacturers
Figure 2016 Cancer Immunotherapy Production Share by Manufacturers
Table China Cancer Immunotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Cancer Immunotherapy Revenue Share by Manufacturers
Table 2016 China Cancer Immunotherapy Revenue Share by Manufacturers
Table China Market Cancer Immunotherapy Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Cancer Immunotherapy Average Price of Key Manufacturers in 2015
Table Manufacturers Cancer Immunotherapy Manufacturing Base Distribution and Sales Area
Table Manufacturers Cancer Immunotherapy Product Type
Figure Cancer Immunotherapy Market Share of Top 3 Manufacturers
Figure Cancer Immunotherapy Market Share of Top 5 Manufacturers
Table Church & Dwight Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Church & Dwight Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
Figure Church & Dwight Cancer Immunotherapy Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Cancer Immunotherapy Market Share (2012-2017)
Table AstraZeneca Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AstraZeneca Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Cancer Immunotherapy Market Share (2012-2017)
Table F. Hoffman La-Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table F. Hoffman La-Roche Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table F. Hoffman La-Roche Cancer Immunotherapy Market Share (2012-2017)
Table Bayer AG Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bayer AG Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Cancer Immunotherapy Market Share (2012-2017)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Bristol-Myers Squibb Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Bristol-Myers Squibb Cancer Immunotherapy Market Share (2012-2017)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Eli Lilly and Company Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly and Company Cancer Immunotherapy Market Share (2012-2017)
Table Janssen Global Services Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Janssen Global Services Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Janssen Global Services Cancer Immunotherapy Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Merck Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Merck Cancer Immunotherapy Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Cancer Immunotherapy Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Cancer Immunotherapy Market Share (2012-2017)
Figure Production Revenue Share of Cancer Immunotherapy by Type (2012-2017)
Figure 2015 Revenue Market Share of Cancer Immunotherapy by Type
Table China Cancer Immunotherapy Price by Type (2012-2017)
Figure China Cancer Immunotherapy Production Growth by Type (2012-2017)
Table China Cancer Immunotherapy Consumption by Application (2012-2017)
Table China Cancer Immunotherapy Consumption Market Share by Application (2012-2017)
Figure China Cancer Immunotherapy Consumption Market Share by Application in 2015
Table China Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
Figure China Cancer Immunotherapy Consumption Growth Rate by Application (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Immunotherapy
Figure Manufacturing Process Analysis of Cancer Immunotherapy
Figure Cancer Immunotherapy Industrial Chain Analysis
Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015
Table Major Buyers of Cancer Immunotherapy
Table Distributors/Traders List
Figure China Cancer Immunotherapy Capacity, Production and Growth Rate Forecast (2017-2021)
Figure China Cancer Immunotherapy Revenue and Growth Rate Forecast (2017-2021)
Table China Cancer Immunotherapy Production, Import, Export and Consumption Forecast (2017-2021)
Table China Cancer Immunotherapy Production Forecast by Type (2017-2021)
Table China Cancer Immunotherapy Consumption Forecast by Application (2017-2021)

COMPANIES MENTIONED

Amgen
AstraZeneca
F. Hoffman La-Roche
Bayer AG
Bristol-Myers Squibb
Eli Lilly and Company
Janssen Global Services
Merck
Novartis
Pfizer
Seattle Genetics
Peregrine Pharmaceuticals
Viralytics Ltd
Immunomedics